Cannabis and Hemp Industry Investment News
The company has entered a research agreement which includes funding under the Kick-Start initiative for SMEs. CannPal is developing therapeutics for a...
() founder and managing director Layton Mills speaks to Proactive Investors about the innovative pet pharmaceutical company, which operates in the med...
CannPal has identified an opportunity in the medical cannabis and health markets. CannPal is a pharmaceutical-focused animal health company () holds a...
CannPal is researching the benefits of medical cannabis for companion animals. CannPal is the only ASX-listed pure animal health company CannPal Anima...
The company listed on the ASX in October 2017 after raising $6M. Clinical trials planned for Q1 CY18. () has been granted an authorisation to possess ...
